Michael Hanna brings to Sinai Health System’s tech transfer office over eighteen years of experience in technology transfer, three of which were spent on the industry side in his role in business development at Regeneron Pharmaceuticals, Inc. (Tarrytown, New York). He has a B.Sc. (honours) in Biology from the University of Waterloo and a M.Sc. in molecular microbiology from the University of Toronto, Faculty of Dentistry. Michael is responsible for a variety of matters at Sinai including review and negotiation of industry-sponsored research agreements, evaluating invention disclosures and other opportunities, marketing, license negotiation and startup creation.